Introduction: Physiologic & functional Ovarian Cysts are most commonly seen in reproductive age group but also to be seen in any age group from infancy to postmenopausal period. Incidence of Ovarian Cyst in gynaec OPD at attending OPD in Dr.V.R.K Hospital is 0.6%. The study was conducted to evaluate the percentage of regression of ovarian cyst with 3 months OCPs (Category II 3 menstrual cycles — either underwent ultrasound follow-up for 3 months or administration of OCP (oral combined pills for 3 months).
Methodology: A prospective study was conducted in which women presenting with complaints such as abdominal pain, bloating, menstrual irregularities, or those found to be asymptomatic but diagnosed with ovarian cysts were evaluated. Diagnosis was established using pelvic ultrasonography (USG) and serum CA-125 levels. Women with ovarian cysts identified on USG were further assessed with CA-125 to exclude pathological conditions. Patients diagnosed with functional ovarian cysts were administered oral contraceptive pills (OCPs) for a period of three months, after which follow-up pelvic USG was performed to assess regression.
Results: Out of about 32 women studied for 3 months: CA125 levels were normal in functional cysts. Ovarian cyst in all 32 cases were of functional type. CA125 levels were raised in Endometriotic cysts. The abnormal cases were ruled out. Regression of functional ovarian cysts was seen with OCP administration. There’s also a small hand-drawn pie chart at the bottom of the page, likely showing data distribution visually.
Conclusion: Combined oral contraceptives significantly promote regression of functional ovarian cysts by suppressing ovulation. CA-125 evaluation is essential to differentiate benign from malignant or complex cysts. Conservative management with OCPs remains an effective first-line option in reproductive-age women.
International Journal of Clinical Obstetrics and Gynaecology
Indexed in Index Copernicus
Research Journals